Q1 2026 Holdings
Filed 2026-11-03 | 14 holdings | $3.0M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2026-11-04) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Schwab US Large-Cap ETF(SCHX) | ETF | 808524201 | $841.1K | 32,805 | 27.6% |
| iShares Msci USA Quality Factor ETF(QUAL) | ETF | 46432F339 | $372.5K | 1,942 | 12.2% |
| Spdr S&P 500 ETF Trust(SPY) | ETF | 78462F103 | $315.3K | 485 | 10.4% |
| Immunome Inc(IMNM) | Stock | 45257U108 | $298.5K | 13,647 | 9.8% |
| Vanguard Growth Index Fund ETF Shares(VUG) | ETF | 922908736 | $224.5K | 514 | 7.4% |
| Zentalis Pharmaceuticals Inc(ZNTL) | Stock | 98943L107 | $201.3K | 86,017 | 6.6% |
| Gamco Natural Resources Gold & Income Trust(GNT) | CEF | 36465E101 | $185.5K | 22,212 | 6.1% |
| Gamco Global Gold, Natural Resources & Income Trust(GGN) | CEF | 36465A109 | $142.6K | 26,803 | 4.7% |
| Morgan Stanley Emerging Markets Domestic Debt Fund, Inc(EDD) | CEF | 617477104 | $119.2K | 23,510 | 3.9% |
| Templeton Emerging Markets Income Fund(TEI) | CEF | 880192109 | $111.2K | 18,500 | 3.7% |
| FS Credit Opportunities Corp.(FSCO) | CEF | 30290Y101 | $108.6K | 21,285 | 3.6% |
| Saba Capital Income & Opportunities Fund II(SABA) | CEF | 880198205 | $101.9K | 12,250 | 3.3% |
| Fate Therapeutics Inc(FATE) | Stock | 31189P102 | $12.0K | 10,000 | 0.4% |
| Irulya Therapeutics Inc COM(QNCX) | Stock | 22053A305 | $9.6K | 94,201 | 0.3% |